Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/9608
DC FieldValueLanguage
dc.contributor.authorIvanovski, Ognenen_US
dc.contributor.authorSzumilak, Dorotaen_US
dc.contributor.authorNguyen-Khoa, Thaoen_US
dc.contributor.authorRuellan, Nadyaen_US
dc.contributor.authorPhan, Olivieren_US
dc.contributor.authorLacour, Bernarden_US
dc.contributor.authorDescamps-Latscha, Béatriceen_US
dc.contributor.authorDrüeke, Tilman Ben_US
dc.contributor.authorMassy, Ziad Aen_US
dc.date.accessioned2020-12-03T11:41:24Z-
dc.date.available2020-12-03T11:41:24Z-
dc.date.issued2005-06-
dc.identifier.issn0085-2538-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9608-
dc.description.abstractCardiovascular disease is the most frequent cause of mortality in chronic renal failure (CRF). Therefore, it is important to identify appropriate treatment measures. The antioxidant N-acetylcysteine (NAC) has been shown to reduce cardiovascular events in hemodialysis patients. Here we examine a possible direct effect of NAC supplementation on uremia-enhanced atherosclerosis in apolipoprotein E-deficient (apoE(-/-)) mice.en_US
dc.language.isoenen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofKidney internationalen_US
dc.titleThe antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout miceen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/j.1523-1755.2005.00332.x-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S0085253815507163?httpAccept=text/plain-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S0085253815507163?httpAccept=text/xml-
dc.identifier.volume67-
dc.identifier.issue6-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

90
checked on May 1, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.